Improving the Early Diagnosis of Osteoporosis in Adults and Children Living in the Abay Region of KazakhstanNCT06344598
Identification and Assessment of Risk Factors for the Development of Osteoporosis in Adults and Children Living in the Abay Region of the Republic of Kazakhstan Using the Method of Dual-energy X-ray Absorptiometry and Clinical and Epidemiological Research
An observational study of Improving the Early Diagnosis of Osteoporosis in Adults and Children Living in the Abay Region of Kazakhstan, run by Semey State Medical University at 1 site in Kazakhstan.
Trial summary
A survey of people to identify risk factors for osteoporosis, which include age, gender, lifestyle, diet, physical activity, the presence or absence of somatic pathology. Diagnosis of osteoporosis by dual-energy X-ray absorptiometry. Conducting a correlation analysis of the relationship of the data obtained. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Improving the Early Diagnosis of Osteoporosis in Adults and Children Living in the Abay Region of Kazakhstan
- How many people
- 1,000 participants
- Where
- 1 siteKazakhstan
- Study dates
- 1 Sep 2023to 31 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Residents of the Abay region of the Republic of Kazakhstan
Inclusion Criteria: adults and children without a history of pathological fractures and congenital pathology of the musculoskeletal system.
-
Exclusion Criteria: adults and children with congenital pathology of the musculoskeletal system
-
Trial locations and contacts
1 site in 1 country.
Kazakhstan1 site, 1 recruiting
- Recruiting
Semey Medical University
Semey, 071400
Madina MD Madiyeva, PhD, +77085244745, madina.madiyeva@smu.edu.kz
Gulzhan MD Bersimbekova, +77023728412, gulzhan.bersimbekova@smu.edu.kz
About this study
Official title: Clinical and Epidemiological Risk Evaluation of Osteoporosis Prevalence at Different Ages With to Assess Bone Quantification Using Dual-energy X-ray Absorptiometry
A survey of people to identify risk factors for osteoporosis, which include age, gender, lifestyle, diet, physical activity, the presence or absence of somatic pathology. Diagnosis of osteoporosis by dual-energy X-ray absorptiometry. Conducting a correlation analysis of the relationship of the data obtained.
Read the detailed description
Successful diagnosis of osteoporosis is possible with the complex use of clinical, laboratory and radiological methods. In the complex of diagnostic methods, a special place has given to dual-energy X-ray absorptiometry, which is the "gold standard". The research area contains the following tasks:
Risk factors for the development of osteoporosis will be identified and quantified in the formed study groups of adults; to determine the diagnostic value of the risk factors for the development of osteoporosis obtained during the examination.
to assess the state of BMD in adults using X-ray absorptiometry (DXA) To carry out a correlation analysis of the relationship between the obtained data in adults of the Abay region of of the Republic of Kazakhstan
- Keywords
- osteoporosis, dual-energy X-ray absorptiometry, bone mineral density, risk factors
- Medical subject headings
- Osteoporosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Persons with normal BMD | Not described | |
| Persons with low BMD | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Risk factors for the development of osteoporosis will be identified and quantified in the formed study groups of adults
Measured: By the end of Dec 2025
to determine the diagnostic value of the risk factors for the development of osteoporosis obtained during the examination
Measured: By the end of Dec 2025
to assess the state of BMD in adults using X-ray absorptiometry (DXA)
Measured: By the end of Dec 2025
To carry out a correlation analysis of the relationship between the obtained data in adults of the Abay region of of the Republic of Kazakhstan
Measured: By the end of Dec 2025
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Apr 2024
- Study start1 Sep 2023
- Primary completion15 Nov 2025 (estimated)
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Improving the Early Diagnosis of Osteoporosis in Adults and Children Living in the Abay Region of KazakhstanStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Semey State Medical University
- Sponsor type
- University, hospital or other
- Collaborators
- Ministry of Science and Higher Education of the Republic of Kazakhstan
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06344598
- Sponsor's protocol ID
- 0123РК00314
- Other IDs
- AP19680262
- Status last verified
- Sep 2023
- First submitted
- 27 Mar 2024
- Last updated
- 3 Apr 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical and Epidemiological Risk Evaluation of Osteoporosis Prevalence at Different Ages With to Assess Bone Quantification Using Dual-energy X-ray Absorptiometry
- ClinicalTrials.gov ID
- NCT06344598
- Acronym / sponsor ID
- 0123РК00314
- Keywords
- osteoporosis, dual-energy X-ray absorptiometry, bone mineral density, risk factors
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Semey State Medical UniversityUniversity, hospital or other
- Collaborators
- Ministry of Science and Higher Education of the Republic of Kazakhstan
- Study start
- 1 Sep 2023 (actual)
- Primary completion
- 15 Nov 2025 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 3 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A survey of people to identify risk factors for osteoporosis, which include age, gender, lifestyle, diet, physical activity, the presence or absence of somatic pathology. Diagnosis of osteoporosis by dual-energy X-ray absorptiometry. Conducting a correlation analysis of the relationship of the data obtained.
Detailed description
Successful diagnosis of osteoporosis is possible with the complex use of clinical, laboratory and radiological methods. In the complex of diagnostic methods, a special place has given to dual-energy X-ray absorptiometry, which is the "gold standard". The research area contains the following tasks:
Risk factors for the development of osteoporosis will be identified and quantified in the formed study groups of adults; to determine the diagnostic value of the risk factors for the development of osteoporosis obtained during the examination.
to assess the state of BMD in adults using X-ray absorptiometry (DXA) To carry out a correlation analysis of the relationship between the obtained data in adults of the Abay region of of the Republic of Kazakhstan
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Persons with normal BMD | – | – |
| Persons with low BMD | – | – |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Residents of the Abay region of the Republic of Kazakhstan
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Risk factors for the development of osteoporosis will be identified and quantified in the formed study groups of adults
Time frame: By the end of Dec 2025
to determine the diagnostic value of the risk factors for the development of osteoporosis obtained during the examination
Time frame: By the end of Dec 2025
to assess the state of BMD in adults using X-ray absorptiometry (DXA)
Time frame: By the end of Dec 2025
To carry out a correlation analysis of the relationship between the obtained data in adults of the Abay region of of the Republic of Kazakhstan
Time frame: By the end of Dec 2025
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2024.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Improving the Early Diagnosis of Osteoporosis in Adults and Children Living in the Abay Region of Kazakhstan, run by Semey State Medical University at 1 site in Kazakhstan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Kazakhstan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Risk factors for the development of osteoporosis will be identified and quantified in the formed study groups of adults (time frame: By the end of Dec 2025). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2024.